Literature DB >> 7344882

Chylomicronemia syndrome in diabetes mellitus.

A Chait, H T Robertson, J D Brunzell.   

Abstract

Lipemic plasma with marked elevations of plasma triglyceride levels (3221 +/- 1590 mg/dl) and fasting chylomicronemia was observed in nine patients with uncontrolled non-insulin-dependent diabetes mellitus. Every case had hypertriglyceridemic relatives, suggesting that the very high triglyceride values seen resulted from the coexistence of diabetes with a familial form of hypertriglyceridemia. A number of clinical and biochemical features observed in the diabetic patients and also in a group of nondiabetic controls with comparable degrees of hypertriglyceridemia suggests that these manifestations are related to high plasma triglyceride levels rather than to the diabetes per se. Chronic abdominal pain, mental confusion, and memory loss improved with lipid-lowering therapy and clearing the plasma of chylomicrons. Pulmonary function tests, red cell 2,3-diphosphoglycerate, and hemoglobin oxygen affinity were normal; the mild hypoxemia observed is believed to be an artifact. It is suggested that a syndrome due to chylomicronemia can occur in uncontrolled non-insulin-dependent diabetic patients, who in addition have a familial form of hypertriglyceridemia. To prevent manifestations of this syndrome in these patients, specific lipid-lowering therapy may be required in addition to control of their diabetes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7344882     DOI: 10.2337/diacare.4.3.343

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

Review 1.  Frailty and hormones.

Authors:  John E Morley; Moon Jong Kim; Matthew T Haren
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 2.  Treatment of Dyslipidemia in Diabetes: Recent Advances and Remaining Questions.

Authors:  Alan Chait; Ira Goldberg
Journal:  Curr Diab Rep       Date:  2017-09-27       Impact factor: 4.810

Review 3.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

4.  Diabetic lipemia with fatty splenomegaly culminating in unnecessary splenectomy.

Authors:  J M Small; F Moatamed; A Deiss; D E Wilson
Journal:  West J Med       Date:  1987-08

5.  Artifactually low glycated haemoglobin in a patient with severe hypertriglyceridaemia.

Authors:  A Garrib; W Griffiths; P Eldridge; R Hatton; A Worsley; M Crook
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

Review 6.  The effect of dietary intervention on serum lipid levels in type 2 diabetes mellitus.

Authors:  Nilo B Cater; Abhimanyu Garg
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

7.  Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin-dependent) diabetic subjects with lipaemia.

Authors:  S M Haffner; D M Foster; R S Kushwaha; W R Hazzard
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

Review 8.  Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.

Authors:  A Ilarde; M Tuck
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

9.  Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor.

Authors:  H Nagasaka; H Kikuta; H Chiba; T Murano; H Harashima; A Ohtake; H Senzaki; N Sasaki; I Inoue; S Katayama; K Shirai; K Kobayashi
Journal:  Eur J Pediatr       Date:  2003-01-23       Impact factor: 3.183

10.  Serum lipids and apolipoproteins in children with type 1 (insulin-dependent) diabetes during the first two years of the disease.

Authors:  M Kobbah; B Vessby; T Tuvemo
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.